Our paper on Cyr61 in NASH Fibrosis is out and on the cover of Science Translational Medicine.
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis.
Mooring et al. Sci Transl Med. 2023 Sep 27;15(715):eade3157.
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis.
Mooring et al. Sci Transl Med. 2023 Sep 27;15(715):eade3157.
(© stock.adobe.com)
Protein that drives liver damage could be a new target for treatment (Yale News)
Yale researchers have identified a protein that drives symptoms of severe liver disease and may be a target for treatment in the future.
Yale researchers have identified a protein that drives symptoms of severe liver disease and may be a target for treatment in the future.
